1. Home
  2. CPF vs ESPR Comparison

CPF vs ESPR Comparison

Compare CPF & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

HOLD

Current Price

$31.84

Market Cap

849.9M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.09

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPF
ESPR
Founded
1954
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
849.9M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CPF
ESPR
Price
$31.84
$3.09
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$34.50
$6.67
AVG Volume (30 Days)
160.7K
5.6M
Earning Date
01-28-2026
03-03-2026
Dividend Yield
3.52%
N/A
EPS Growth
15.70
N/A
EPS
2.43
N/A
Revenue
$260,672,000.00
$303,802,000.00
Revenue This Year
$1.70
$26.11
Revenue Next Year
$7.10
N/A
P/E Ratio
$13.11
N/A
Revenue Growth
6.55
2.83
52 Week Low
$23.16
$0.69
52 Week High
$33.35
$4.18

Technical Indicators

Market Signals
Indicator
CPF
ESPR
Relative Strength Index (RSI) 51.90 32.93
Support Level $30.42 $3.00
Resistance Level $32.53 $4.18
Average True Range (ATR) 0.75 0.23
MACD -0.06 -0.11
Stochastic Oscillator 58.19 4.26

Price Performance

Historical Comparison
CPF
ESPR

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: